Annji Pharmaceutical Co (ROCO:7754) Research & Development: NT$339.86 Mil (TTM As of Dec. 2025)


ROCO:7754 Annji Pharmaceutical Co Ltd ROCO:7754
9 GF Score
Price NT$58.70
! 3 Warning Signs
View Full Analysis

What is Annji Pharmaceutical Co Research & Development?

Annji Pharmaceutical Co ROCO:7754 -0.68% 9 Research & Development is NT$339.86 Mil as of Dec. 2025. GuruFocus rates ROCO:7754 with a GF Score™ of 9/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Annji Pharmaceutical Co's Research & Development for the six months ended in Dec. 2025 was NT$175.52 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$339.86 Mil.

Annji Pharmaceutical Co  (ROCO:7754) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Annji Pharmaceutical Co Research & Development Related Terms

Annji Pharmaceutical Co Research & Development Historical Data

* Premium members only.

The historical data trend for Annji Pharmaceutical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Annji Pharmaceutical Co Research & Development Chart

Annji Pharmaceutical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
184.42 223.43 247.15 321.49 339.86

Annji Pharmaceutical Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial 132.00 174.61 146.88 164.34 175.52
ROCO:7754
9GF Score
Annji Pharmaceutical Co Ltd ROCO:7754
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Annji Pharmaceutical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$339.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$339.86 Mil mean?
Annji Pharmaceutical Co (ROCO:7754) has a Research & Development of NT$339.86 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Annji Pharmaceutical Co and its competitors.
Is Annji Pharmaceutical Co's Research & Development too high?
Annji Pharmaceutical Co's current Research & Development is NT$339.86 Mil. Overall, Annji Pharmaceutical Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Annji Pharmaceutical Co's Research & Development compare to VRTX and REGN?
Annji Pharmaceutical Co's Research & Development of NT$339.86 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Annji Pharmaceutical Co and its competitors. Annji Pharmaceutical Co's current Research & Development is NT$339.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Annji Pharmaceutical Co stock overvalued right now?
Annji Pharmaceutical Co (ROCO:7754) has a current Research & Development of NT$339.86 Mil. The current Research & Development is NT$339.86 Mil. Annji Pharmaceutical Co's overall GF Score™ is 9/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Annji Pharmaceutical Co (ROCO:7754), the current Research & Development is NT$339.86 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Annji Pharmaceutical Co Business Description

Address Zhongxiao E. Raod, 16th Floor-6, No. 508, Sector 7, Nangang Distrist, Taipei, TWN, 115011
Annji Pharmaceutical Co Ltd is an R&D based, clinical-stage new drug company dedicated to the development of first-in-class small molecules focusing on indications with highly unmet needs in the therapeutic areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy's disease, or SBMA (Spinal and bulbar muscular atrophy). Its pipeline products include AJ201, AJ302 and AJ303.
9GF Score

Get the complete analysis for ROCO:7754

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$58.70
Price